Starting on the 1 June, the DENSTAR project will work to advance the licensure of the dengue vaccine DengiAll in sub-Saharan Africa (sSA) and to…
Starting on 1 June 2026, the IMPACT project aims to develop the first antibody-based countermeasure for orthopoxviruses. The project targets both variola major virus (VARV)…
The European Vaccines Hub (EVH) for Pandemic Readiness, convenes its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from…
The Health Emergency Preparedness and Response Authority (HERA) of the European Commission, through the European Health and Digital Executive Agency (HaDEA) supports the establishment of…
It is a pleasure to announce that the new report “Microbial Solutions for Climate Change: Toward an Economically Resilient Future” has been released by the…
The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilised more than € 33 million to support Inno4vac, an innovative public-private partnership to accelerate vaccine R&D…
La Toscana leader nella definizione delle future priorità della ricerca e sviluppo nel settore dei vaccini in Europa. Nei giorni scorsi il partenariato europeo IPROVE (Innovation Partnership…
FIRENZE – La Toscana leader nella definizione delle future priorit della ricerca e sviluppo nel settore dei vaccini in Europa. Nei giorni scorsi il partenariato…